{"id":"https://openalex.org/W4404064483","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0809","title":"809 Exploring the therapeutic benefit of AVA-NP-695 (ENPP1 inhibitor) and DNA damage inhibition to activation of the immune system in metastatic osteosarcoma","display_name":"809 Exploring the therapeutic benefit of AVA-NP-695 (ENPP1 inhibitor) and DNA damage inhibition to activation of the immune system in metastatic osteosarcoma","alternate_titles":[],"publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404064483","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0809"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2024-sitc2024.0809","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0809","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0809","pdf_url":"https://jitc.bmj.com/content/jitc/12/Suppl_2/A914.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4404064483"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/12/Suppl_2/A914.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009437369","display_name":"Borja Ruiz\u2010Fern\u00e1ndez de C\u00f3rdoba","orcid":"https://orcid.org/0000-0002-8638-8012","observed_orcids":["https://orcid.org/0000-0002-8638-8012"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Borja Ruiz Fernandez de Cordoba","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046581323","display_name":"Avijit Goswami","orcid":"https://orcid.org/0000-0002-3636-264X","observed_orcids":["https://orcid.org/0000-0002-3636-264X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Avijit Goswami","raw_affiliation_strings":["Aten Porus Lifesciences, Bangalore, Karnataka, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aten Porus Lifesciences, Bangalore, Karnataka, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049544741","display_name":"Sandeep Goyal","orcid":"https://orcid.org/0000-0001-6915-9835","observed_orcids":["https://orcid.org/0000-0001-6915-9835"]},"institutions":[{"id":"https://openalex.org/I4210139967","display_name":"Atossa Therapeutics (United States)","ror":"https://ror.org/03yqekx34","country_code":"US","type":"company","lineage":["https://openalex.org/I4210139967"]},{"id":"https://openalex.org/I4210155800","display_name":"Levin Institute","ror":"https://ror.org/05gb36730","country_code":"US","type":"education","lineage":["https://openalex.org/I4210155800"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandeep Goyal","raw_affiliation_strings":["Aten Porus Lifesciences, Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Aten Porus Lifesciences, Levittown, PA, USA","institution_ids":["https://openalex.org/I4210139967","https://openalex.org/I4210155800"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102244161","display_name":"Kawaljit Singh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097285","display_name":"Aimmune Therapeutics (United Kingdom)","ror":"https://ror.org/00rrpnq66","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210097285"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kawaljit Singh","raw_affiliation_strings":["Avammune Therapeutics Inc., Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avammune Therapeutics Inc., Levittown, PA, USA","institution_ids":["https://openalex.org/I4210097285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055347652","display_name":"Princy Khurana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097285","display_name":"Aimmune Therapeutics (United Kingdom)","ror":"https://ror.org/00rrpnq66","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210097285"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Princy Khurana","raw_affiliation_strings":["Avammune Therapeutics Inc., Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avammune Therapeutics Inc., Levittown, PA, USA","institution_ids":["https://openalex.org/I4210097285"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009137011","display_name":"Aditya Kulkarni","orcid":"https://orcid.org/0000-0002-7084-428X","observed_orcids":["https://orcid.org/0000-0002-7084-428X"]},"institutions":[{"id":"https://openalex.org/I4210097285","display_name":"Aimmune Therapeutics (United Kingdom)","ror":"https://ror.org/00rrpnq66","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210097285"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Aditya Kulkarni","raw_affiliation_strings":["Avammune Therapeutics Inc., Levittown, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Avammune Therapeutics Inc., Levittown, PA, USA","institution_ids":["https://openalex.org/I4210097285"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5026362990","display_name":"Alejandro Sweet-Cordero","orcid":"https://orcid.org/0000-0002-9787-9351","observed_orcids":["https://orcid.org/0000-0002-9787-9351"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro Sweet-Cordero","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A914","last_page":"A914"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.6679999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.6679999828338623,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.1177000030875206,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.04830000177025795,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cgamp","display_name":"cGAMP","score":0.6389999985694885},{"id":"https://openalex.org/keywords/cgas-sting-pathway","display_name":"cGAS-STING pathway","score":0.9660000205039978},{"id":"https://openalex.org/keywords/metastatic-osteosarcoma","display_name":"metastatic osteosarcoma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/chromosomal-instability","display_name":"chromosomal instability","score":0.953000009059906},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.6069999933242798},{"id":"https://openalex.org/keywords/immune-evasion","display_name":"immune evasion","score":0.6039999723434448},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.4350000023841858},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7459999918937683},{"id":"https://openalex.org/keywords/canine-osteosarcoma","display_name":"canine osteosarcoma","score":0.6539999842643738},{"id":"https://openalex.org/keywords/tumor-shrinkage","display_name":"tumor shrinkage","score":0.3490000069141388},{"id":"https://openalex.org/keywords/micronuclei","display_name":"micronuclei","score":0.4659999907016754},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.7379999756813049},{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.5820000171661377}],"concepts":[{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.6404004693031311},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6055983901023865},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5619509220123291},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.47969529032707214},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.37476611137390137},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32055723667144775},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.18973875045776367},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07824310660362244}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2024-sitc2024.0809","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0809","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0809","pdf_url":"https://jitc.bmj.com/content/jitc/12/Suppl_2/A914.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2024-sitc2024.0809","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0809","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0809","pdf_url":"https://jitc.bmj.com/content/jitc/12/Suppl_2/A914.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404064483.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4415900216","https://openalex.org/W4409690269","https://openalex.org/W4296131254","https://openalex.org/W4311098666","https://openalex.org/W4388047669","https://openalex.org/W4308394516","https://openalex.org/W4362592252","https://openalex.org/W4303959019","https://openalex.org/W4388089593","https://openalex.org/W4388042424"],"abstract_inverted_index":{"Background":[0],"The":[1,109,141,341],"osteosarcoma":[2],"(OS)":[3,181],"genome":[4],"is":[5,13,22,56,63],"characterized":[6],"by":[7,116],"high":[8,48],"chromosomal":[9],"instability":[10],"(CIN).":[11],"CIN":[12,31,51],"a":[14,199,203,226,277,294,356],"hallmark":[15],"of":[16,43,50,92,102,112,126,143,205,260,344,363],"many":[17],"human":[18,53,136],"cancers,":[19,54],"and":[20,28,37,122,131,134,151,156,182,195,218,228,236,247,254,275,318,329,337,348,376,392],"it":[21,55],"associated":[23],"with":[24,159,193,216,303,308,351,380],"metastasis,":[25],"immune":[26,68,72,105,332],"evasion,":[27],"therapeutic":[29,361],"resistance.":[30],"leads":[32],"to":[33,66,80,94,325],"Micronuclei":[34],"(MN)":[35],"formation":[36],"cytosolic":[38],"dsDNA,":[39],"resulting":[40],"in":[41,52,128,147,157,177,202,244,252,268,280,306,310,322,334,346,365,382,387],"activation":[42],"the":[44,90,99,135,170,221,360],"cGAS-STING":[45],"pathway.":[46],"Given":[47],"levels":[49,174,274,282],"not":[57],"surprising":[58],"that":[59,169,378],"this":[60],"anti-tumoral":[61],"axis":[62],"paradoxically":[64],"co-opted":[65],"provide":[67],"evasion":[69],"rather":[70],"than":[71],"surveillance.":[73],"Some":[74],"CIN-high":[75],"cancers":[76],"switch":[77],"from":[78,293],"IFN":[79],"NF-\u03ba\u03b2":[81],"\u2018non-canonical\u2019":[82],"STING-mediated":[83],"signaling.":[84],"CINhigh":[85],"tumors":[86,367],"can":[87],"also":[88],"induce":[89],"expression":[91,173],"ENPP1":[93,172,187,196,212,232],"hydrolyze":[95],"cGAMP,":[96],"which":[97,239],"dampens":[98],"downstream":[100],"effects":[101,243],"cGAMP":[103,189,273,281,320],"on":[104],"cell":[106,207,237],"activation.":[107],"Methods":[108],"inhibition":[110],"potency":[111],"AVA-NP-695":[113,127,144,261,271,309,345,364,381],"was":[114,139,145],"confirmed":[115],"enzymatic":[117],"assays":[118],"using":[119,198],"substrates":[120],"p-Nitrophenyl-5\u2032-TMP":[121],"2\u20323\u2032-cGAMP.":[123],"Pharmacokinetic":[124],"profile":[125,138,354],"Mice,":[129],"Rats":[130],"Beagle":[132],"Dogs":[133],"PK":[137],"predicted.":[140],"efficacy":[142,343],"demonstrated":[146],"F420-":[148],"C57/BL6":[149],"mice":[150,153,253],"K7M2-BALB/c":[152],"as":[154,285,287],"monotherapy":[155,347],"combination":[158,307,314,349,383],"clinically":[160],"approved":[161],"DDR-inhibitors":[162],"like":[163,368],"Olaparib.":[164],"Results":[165,292],"RNAseq":[166],"data":[167],"revealed":[168],"highest":[171],"were":[175],"found":[176],"Ewing":[178],"sarcoma,":[179],"Osteosarcoma":[180],"breast":[183],"cancer.":[184],"We":[185,223],"evaluated":[186],"expression,":[188],"export":[190],"after":[191,290],"stimulation":[192],"dsDNA":[194],"activity":[197,213],"biochemical":[200],"assay":[201],"panel":[204],"OS":[206,326],"lines,":[208],"including":[209],"OSPDX-cell":[210],"lines.":[211],"varied":[214],"significantly,":[215],"OS384":[217],"OS526":[219],"having":[220],"highest.":[222],"tested":[224],"AVA-NP-695,":[225],"selective":[227],"potent":[229],"small":[230],"molecule":[231],"inhibitor,":[233],"orally":[234],"bioavailable":[235],"permeable":[238],"exhibited":[240],"no":[241],"adverse":[242],"repeat":[245],"dose":[246,248],"escalation":[249],"toxicity":[250],"studies":[251],"beagle":[255],"dogs.":[256],"Moreover,":[257],"compassionate":[258],"use":[259],"showed":[262],">":[263],"80%":[264],"tumor":[265,327],"volume":[266],"reduction":[267],"Canine":[269],"patients.":[270],"restored":[272],"observed":[276],"significant":[278],"increase":[279,385],"(~2\u20133":[283],"fold)":[284],"early":[286],"6":[288],"hours":[289],"treatment.":[291],"targeted":[295],"pharmacological":[296],"screen":[297],"uncovered":[298],"an":[299],"unexpectedly":[300],"synthetic":[301],"lethality":[302],"Olaparib":[304],"(PARPi)":[305],"vitro.":[311],"This":[312],"novel":[313,373],"increased":[315],"both":[316,335],"intra-":[317],"extracellular":[319],"production":[321],"vitro,":[323],"led":[324],"regression":[328],"boosts":[330],"antitumor":[331],"responses":[333],"OT":[336],"metastatic":[338],"context.":[339],"Conclusions":[340],"anti-tumor":[342],"along":[350],"its":[352],"safety":[353],"provides":[355],"strong":[357],"rationale":[358],"for":[359],"potential":[362],"pediatrics":[366],"Osteosarcoma.":[369],"Our":[370],"results":[371],"uncover":[372],"mechanistic":[374],"vulnerabilities":[375],"suggest":[377],"treatment":[379],"may":[384],"effectiveness":[386],"patients,":[388],"thus":[389],"preventing":[390],"local":[391],"distant":[393],"dissemination.":[394]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4404064483","counts_by_year":[],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2024-11-06T00:00:00"}
